| [1] |
Zheng RS, Chen R, Han BF，et al.Cancer incidence and mortality in China，2022[J].Zhonghua Zhong Liu Za Zhi，2024，46(3): 221-231.
|
| [2] |
Ota T, HasegawaY, Okimura A, et al.Breast metastasis from EGFR-mutated lung adenocarcinoma：a case report and review of the literature[J]. Clin Case Rep，2018，6(8): 1510-1516.
|
| [3] |
Valenza C, Porta FM, Rappa A，et al. Complex differential diagnosis between primary breast cancer and breast metastasis from EGFR-mutated lung adenocarcinoma: case report and literature review[J].Curr Oncol，2021，28(5): 3384-3392.
|
| [4] |
Passaro A, Jänne PA, Mok T, et al. Overcoming therapy resistance in EGFR-mutant lung cancer[J]. Nat Cancer, 2021, 2(4): 377-391.
|
| [5] |
Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: non-small cell lung cancer, version 1.2020[J]. J Natl Compr Canc Netw, 2019, 17(12): 1464-1472.
|
| [6] |
Wang B, Jiang Y, Li SY, et al. Breast metastases from primary lung cancer：a retrospective case series on clinical, ultrasonographic, and immunohistochemical features[J].Transl Lung Cancer Res，2021，10(7): 3226-3235.
|
| [7] |
Wang L, Wang SL, Shen HH，et al.Breast metastasis from lung cancer: a report of two cases and literature review[J].Cancer Biol Med，2014，11(3): 208-215.
|
| [8] |
Mun SH, Ko EY, Han BK，et al.Breast metastases from extramammary malignancies：typical and atypical ultrasound features[J].Korean J Radiol，2014，15(1): 20-28.
|
| [9] |
Lee SH, Park JM, Kook SH，et al.Metastatic tumors to the breast: mammographic and ultrasonographic findings[J].Ultrasound Med，2000，19(4): 257-262.
|
| [10] |
Yeh CN, Lin CH, Chen MF.Clinical and ultrasonographic characteristics of breast metastases from extramammary malignancies[J].Am Surg，2004，70(4): 287-290.
|
| [11] |
Güldoǧan N, Içten GE, Tokat F, et al. Three cases of breast metastases from lung cancer and systematic review of the literature[J].Eur J Breast Health，2021，17(2): 200-205.
|
| [12] |
Chuang WY, Yeh CJ, Chu PH，et al.Expression of thyroid transcription factor-1 in brain metastases: a useful indicator of pulmonary origin[J].Clin Neurosci，2008，15(6): 643-646.
|
| [13] |
Li Y, Shang Y, Wang W, et al. Lung cancer and pulmonary embolism: what is the relationship? A review[J].Cancer，2018，9(17)：3046-3057.
|
| [14] |
Lee JW, Cha SI, Jung CY, et al. Clinical course of pulmonary embolism in lung cancer patients[J]. Respiration，2009，78(1): 42-48.
|
| [15] |
马军，秦叔逵，吴一龙，等. 肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版)[J].中国肿瘤临床，2019, 46(13)：653-660.
|
| [16] |
Dong Y, Wang Y, Ma RL, et al. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis[J].Thromb Thrombolysis，2019，48(3): 400-412.
|